Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca Pharma India MD Anandh Balasundaram resigns

Chief operating officer Jonathan Hunt will take over on an interim basis

The managing director of AstraZeneca's Indian subsidiary Anandh Balasundaram has resigned and will leave the company at the end of this week.

He has held the role since 2007, having previously spent two years as vice president of sales and marketing at Bangalore-based AstraZeneca Pharma India.

Balasundaram will be replaced on an interim basis by chief operating officer Jonathan Hunt, who will initially hold the role for four months, according to a filing made last week to the Bombay Stock Exchange.

28th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics